Clinical Trial

Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)

Study acronym: NEPTUN2
Recruiting
View on ClinicalTrials.gov →
Summary
Evaluation of non-invasive prognostic parameters in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) for complications of portal hypertension. Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-05-16.
Trial Details
NCT Number NCT04393519
Lead Sponsor University Hospital, Bonn
Conditions Portal Hypertension
Enrollment 1,000 participants
Start Date 2020-05-12
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-10-05